CARPL.ai vs Aidoc
A detailed comparison to help you choose between CARPL.ai and Aidoc.
🏆
Verdict: Aidoc wins
Aidoc scores 4.2/5, edging out CARPL.ai at 3.9/5. Hospital radiology departments and integrated health systems with meaningful acute imaging volumes that want one governed platform for many FDA-cleared triage algorithms instead of a stack of point solutions.
CARPL.ai AI-powered radiology platform for seamless healthcare integration | Aidoc AI powered radiology image analysis platform | |
|---|---|---|
| Rating | 3.9 (1 review) | 4.2 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $99/mo | From $10000/mo |
| Best For | Hospital radiology departments and imaging networks that want to evaluate, deploy and monitor AI from many vendors through one PACS integration instead of contracting each algorithm separately. | Hospital radiology departments and integrated health systems with meaningful acute imaging volumes that want one governed platform for many FDA-cleared triage algorithms instead of a stack of point solutions. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | api accessteam featuresgdpr compliant | api accessteam featuresgdpr compliant |
| Visit CARPL.ai → | Visit Aidoc → |
CARPL.ai
Pros
- + Single integration point replaces per-vendor AI integrations; the PACS/RIS-agnostic gateway design is documented in the 510(k) summary, not just marketing
- + Validation-before-purchase workflow runs candidate algorithms on your own institutional data with AUC, bias and fairness reports before any contract
- + Universal AI Viewer handles a wider range of AI output formats than most single-vendor tools — DICOM SEG, GSPS, structured reports, ROI coordinates and secondary captures
- + Regulatory transparency is better than the category norm: each hosted algorithm shows its own FDA 510(k) number with a link to the decision letter
- + On-premise, private cloud or any major cloud deployment, with named PACS partners (Agfa, Intelerad, DeepHealth, Ramsoft, PaxeraHealth)
Cons
- - No public pricing, no self-serve trial and no free tier — every evaluation goes through an enterprise sales process
- - The FDA 510(k) clearance covers image management and viewing only; it carries no diagnostic performance claim and validates none of the hosted algorithms
- - Marketplace counts conflict across CARPL's own pages (110+ apps in May 2024, 175+ in June 2025, 275+ and 300+ on the current homepage)
- - Mammography use is restricted: no lossy-compressed or digitised film for primary interpretation, and compliant displays are required
- - Built for institutional IT — there is no path for an individual radiologist or small practice, and customers cannot add algorithms themselves
Aidoc
Pros
- + Widest FDA-cleared acute triage portfolio I have reviewed: 31 authorisations on the FDA's December 2025 list, plus the first multi-indication clearance covering 14 abdominal CT findings in one workflow
- + Multi-triage consolidation meaningfully reduces alert noise — one flagged study produces one stacked panel, not one pop-up per algorithm
- + Real-world deployment evidence: Mercy Health documented urgent case turnaround falling from 19.8h to 1.3h across 50+ hospitals, with 5,642 patients expedited from 50,749 flagged findings
- + Vendor-neutral aiOS layer lets a health system run third-party and Aidoc algorithms through one governance and notification stack (17 FDA-cleared algorithms deployed at Hartford HealthCare)
- + Care Coordination and Patient Management close the loop beyond triage: mobile alerts with image context, and report mining that routes incidental findings to facility-defined follow-up protocols
Cons
- - No public pricing, no trial, no free tier — third-party estimates of ~$50k/site/year baseline with $8k-$15k per extra module are unverifiable until you are deep in a sales process
- - Hospital-only: requires PACS/RIS/EHR integration work, so it is irrelevant to individual clinicians, small practices and low-volume facilities
- - 510(k) clearance for most modules does not itself require independent clinical performance data (per JAMA Network Open) — buyers should demand the study set, not just the clearance count
- - No public changelog for algorithm updates, which is a real gap for a system whose output feeds clinical decisions
- - Vendor performance figures (order-of-magnitude false-alert reduction, 1,600+ hospitals) are company claims I could not independently audit
Frequently Asked Questions
Which is better, CARPL.ai or Aidoc?▼
Aidoc scores higher at 4.2/5 vs 3.9/5 for CARPL.ai, making it the better-rated option in our comparison.
What is the difference between CARPL.ai and Aidoc?▼
CARPL.ai: CARPL.ai is a vendor-neutral platform for radiology AI, letting hospitals test, deploy and monitor imaging algorithms through one interface. Aidoc: Aidoc analyses medical imaging to flag urgent findings for radiologists and care teams, prioritising the cases that need attention first.
Is CARPL.ai or Aidoc more affordable?▼
CARPL.ai starts at €99/mo, Aidoc starts at €10000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.